The Clorox Company (NYSE:CLX) Shares Sold by Savoir Faire Capital Management L.P.

Savoir Faire Capital Management L.P. reduced its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 44.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 31,815 shares of the company's stock after selling 25,186 shares during the period. Clorox comprises 2.6% of Savoir Faire Capital Management L.P.'s investment portfolio, making the stock its 16th largest holding. Savoir Faire Capital Management L.P.'s holdings in Clorox were worth $5,183,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Innealta Capital LLC purchased a new position in Clorox in the second quarter valued at $30,000. Trifecta Capital Advisors LLC boosted its holdings in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after purchasing an additional 130 shares in the last quarter. Family Firm Inc. purchased a new position in shares of Clorox in the 2nd quarter valued at $31,000. Quarry LP grew its holdings in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after purchasing an additional 114 shares during the last quarter. Finally, EntryPoint Capital LLC purchased a new position in Clorox during the 1st quarter worth approximately $39,000. Hedge funds and other institutional investors own 78.53% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CLX. TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and raised their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research report on Friday, October 11th. Evercore ISI dropped their price target on Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research report on Monday, October 14th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research note on Friday, August 2nd. Finally, DA Davidson boosted their target price on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research note on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $155.00.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.57% of the company's stock.

Clorox Trading Down 0.6 %

Shares of NYSE CLX traded down $0.94 during midday trading on Tuesday, hitting $168.16. The stock had a trading volume of 1,075,779 shares, compared to its average volume of 1,242,177. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $169.21. The company has a fifty day moving average price of $162.53 and a 200 day moving average price of $147.73. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company has a market capitalization of $20.81 billion, a price-to-earnings ratio of 58.59, a PEG ratio of 3.10 and a beta of 0.41.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company posted $0.49 earnings per share. The firm's revenue was up 27.0% compared to the same quarter last year. On average, analysts predict that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 2.90%. Clorox's dividend payout ratio (DPR) is 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.